Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Hye-Young Ji"'
Autor:
Bikalpa Dhakal, Saugat Shiwakoti, Eun-Young Park, Ki-Woon Kang, Valérie B. Schini-Kerth, Sun-Hwa Park, Hye-Young Ji, Joon Seok Park, Ju-Young Ko, Min-Ho Oak
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Nano plastics (NPs) have been a significant threat to human health and are known to cause premature endothelial senescence. Endothelial senescence is considered one of the primary risk factors contributing to numerous cardiovascular disorder
Externí odkaz:
https://doaj.org/article/6fecc4197a8a4a8ea721238527d07d0f
Autor:
Minyeong Pang, So Yeon Jeon, Min-Koo Choi, Ji-Hyeon Jeon, Hye-Young Ji, Ji-Soo Choi, Im-Sook Song
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1210 (2022)
This study investigated the pharmacokinetics and tissue distribution of enavogliflozin, a novel sodium-glucose cotransporter 2 inhibitor that is currently in phase three clinical trials. Enavogliflozin showed dose-proportional pharmacokinetics follow
Externí odkaz:
https://doaj.org/article/41af35fa7d094e4d87208c95aed329b3
Autor:
Ju-Hyun Kim, Dong Kyun Kim, Won-Gu Choi, Hye-Young Ji, Ji-Soo Choi, Im-Sook Song, Sangkyu Lee, Hye Suk Lee
Publikováno v:
Pharmaceutics, Vol 12, Iss 9, p 865 (2020)
DWP16001 is currently in a phase 2 clinical trial as a novel anti-diabetes drug for the treatment of type 2 diabetes by selective inhibition of sodium-glucose cotransporter 2. This in vitro study was performed to compare the metabolism of DWP16001 in
Externí odkaz:
https://doaj.org/article/1a2e54366a22458880f4054e765ee247
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 268 (2020)
Since sodium-glucose cotransporter 2 (SGLT2) inhibitors reduced blood glucose level by inhibiting renal tubular glucose reabsorption mediated by SGLT2, we aimed to investigate the pharmacokinetics and kidney distribution of DWP16001, a novel SGLT2 in
Externí odkaz:
https://doaj.org/article/ebbea59424b440a8845e2bd0d8fe0638
Autor:
Min-Soo Kim, Yoo-Kyung Song, Ji-Soo Choi, Hye Young Ji, Eunsuk Yang, Joon Seok Park, Hyung Sik Kim, Min-Joo Kim, In-Kyung Cho, Suk-Jae Chung, Yoon-Jee Chae, Kyeong-Ryoon Lee
Publikováno v:
Pharmaceutics; Volume 15; Issue 3; Pages: 942
Enavogliflozin is a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor approved for clinical use in South Korea. As SGLT2 inhibitors are a treatment option for patients with diabetes, enavogliflozin is expected to be prescribed in various pop
Autor:
Yeji Yang, Hyunjin Kim, Minjung Kang, Hyunjin Baik, Yunseok Choi, Eu-Jean Jang, Eun-Jin Chang, Sukyoung Yun, Miok Park, Eunyeong Park, Hojun Yun, Taek-Joo Lee, Yeong-Han Kwon, Kwang-Pyo Hong, Ai-Ran Lee, Songhie Jung, Tai-Hyeon Ahn, Hye-Young Jin, Kee-Hong Choi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract During the COVID-19 pandemic, the world population faced various mental health challenges, highlighting a need for new community-based psychosocial interventions. This study aimed to investigate the effectiveness and feasibility of Nature-Ba
Externí odkaz:
https://doaj.org/article/90a983d9f3da44419f29f9bb6bfc659d
Autor:
Dong Kyun Kim, Hye Suk Lee, Won-Gu Choi, Sangkyu Lee, Ju-Hyun Kim, Hye-Young Ji, Ji-Soo Choi, Im-Sook Song
Publikováno v:
Pharmaceutics
Volume 12
Issue 9
Pharmaceutics, Vol 12, Iss 865, p 865 (2020)
Volume 12
Issue 9
Pharmaceutics, Vol 12, Iss 865, p 865 (2020)
DWP16001 is currently in a phase 2 clinical trial as a novel anti-diabetes drug for the treatment of type 2 diabetes by selective inhibition of sodium-glucose cotransporter 2. This in vitro study was performed to compare the metabolism of DWP16001 in
Publikováno v:
Pharmaceutics
Volume 12
Issue 3
Pharmaceutics, Vol 12, Iss 3, p 268 (2020)
Volume 12
Issue 3
Pharmaceutics, Vol 12, Iss 3, p 268 (2020)
Since sodium-glucose cotransporter 2 (SGLT2) inhibitors reduced blood glucose level by inhibiting renal tubular glucose reabsorption mediated by SGLT2, we aimed to investigate the pharmacokinetics and kidney distribution of DWP16001, a novel SGLT2 in
Autor:
Hye Young Ji, Miwon Son, Sang-Zin Choi, Yong-Yeon Cho, Hyeon-Uk Jeong, Hye Suk Lee, Ji Young Lee
Publikováno v:
Yakhak Hoeji. 62:226-236
DA-9801, a mixed extract of Dioscoreae japonica and Dioscorea nipponica Makino, is awaiting phase 3 clinical study for the prevention or treatment of...
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
BackgroundNature-based therapy (NBT), which centers around engaging in activities within natural surroundings, has consistently demonstrated therapeutic benefits for mental health. While NBT highlights the potential of nature as a therapeutic resourc
Externí odkaz:
https://doaj.org/article/b06a1d850dc848ed82da1a560c915344